Inactive Instrument

MusclePharm Corporation Stock Other OTC

Equities

Duration

Period

Style

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	23-10-18	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	23-10-09	CI
Motion for Asset Sale Approved for MusclePharm Corporation	23-10-03	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	23-09-26	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	23-09-08	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	23-08-31	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	23-08-28	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	23-08-28	CI
Bidding Procedure Approved for MusclePharm Corporation	23-08-17	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	23-07-19	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	23-06-19	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	23-05-26	CI
Motion for Asset Sale Filed by MusclePharm Corporation	23-05-12	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	23-05-10	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	23-04-16	CI

SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	23-06-28	AQ
MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	22-09-29	AQ
MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	22-09-19	PU
MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	22-09-19	AQ
MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	22-08-23	AQ

Managers	Title	Age	Since
Eric Hillman CEO	Chief Executive Officer	-	23-02-12
Eric Chin DFI	Director of Finance/CFO	44	22-06-16
Ryan Charles Drexler CHM	Chairman	53	15-08-25

Members of the board	Title	Age	Since
Eric Hillman CEO	Chief Executive Officer	-	23-02-12
Michael Heller BRD	Director/Board Member	48	21-01-18
Ryan Charles Drexler CHM	Chairman	53	15-08-25

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

Calendar

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+168.57%	6.83B
SCREAMING EAGLE ACQUISITION CORP.	+0.29%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+21.59%	797M
ARES ACQUISITION CORPORATION II	+1.82%	664M
E7 GROUP	-1.80%	617M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+30.63%	592M